PATENT CLAIM ANALYSIS

Application Number: 15750849
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["540", "492000"]

Abstract:
The present invention relates to crystalline form C of avibactam sodium and to a process for its preparation. The invention also concerns a pharmaceutical composition comprising form C and one or more antibacterial agents, wherein at least one antibacterial agent is a beta-lactam antibiotic. The pharmaceutical composition of the present invention can be used as medicament, in particular for treatment and/or prevention of bacterial infections.

Claim (Index 4):
The crystalline form C according to  claim 1  characterized by having\n (i) a Fourier transform infrared spectrum comprising peaks at wavenumbers of (3459\u00b12) cm \u22121 , (1690\u00b12) cm \u22121 , (1287\u00b12) cm \u22121 , (1247\u00b12) cm \u22121  and (690\u00b12) cm \u22121 , when measured at a temperature in the range of from 20 to 30\u00b0 C. with a diamond ATR cell, and/or \n (ii) an equilibrium relative humidity of about 55% or less, when measured at a temperature in the range of from 20 to 30\u00b0 C.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.42857
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15560519', '15560527', '14429388', '16073366', '15329673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6093874308912494
- 35 USC 102 Novelty (BERT): 0.4910409103330302
- Combined Prediction Score: 0.5975527788354275
- Mean Citation Score: 179.43415199999995
- Max Citation Score: 185.02882
- Similarity Product: 135.11672249544856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test